Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bis(Adenosine)-5'-Pentaphosphate is a synthetic dinucleotide composed of two adenosine molecules linked via a pentaphosphate chain at their 5' positions. It is also known as diadenosine pentaphosphate or Ap5A. This compound acts as a vasoconstrictor agent and has been identified as an Escherichia coli metabolite. In biological systems, it can interact with enzymes such as adenylate kinase, which plays a role in cellular energy homeostasis by catalyzing the reversible transfer of phosphate groups between ATP and AMP[1][2]. Bis(Adenosine)-5'-Pentaphosphate is primarily used experimentally to study nucleotide metabolism and purinergic signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bis(adenosine)-5'-pentaphosphate.